Status: Not yet recruiting
GS1-144 in Participants With Hepatic Impairment and Healthy Female
GS1-144 in Participants with Hepatic Impairment and Healthy Female
Participants needed: 24
Trial details
Phase: Phase 1Age: 18-70Biological sex: FemaleType: InterventionalSponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Updated: Mar 24, 2026Locations: 1
Eligibility criteria
Participants who sign the ICF prior to the trial, have a full understanding of t... [+8]
Allergic constitution (e.g., allergy to more than two drugs or foods), or a hist... [+18]